The clinical features, CMR characteristics and outcomes of arrhythmogenic left ventricular cardiomyopathy (ALVC), which is a very rare nonischemic cardiomyopathy, are currently not well studied. The ...

Whether revascularization by percutaneous coronary intervention (PCI) can improve event-free survival and left ventricular function in patients with severe ischemic left ventricular systolic ...

Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...

Impella CP is a percutaneously inserted left ventricular assist device indicated for temporary mechanical cardiac support during high risk percutaneous coronary interventions and for cardiogenic shock ...

Heart failure occurs when the heart is unable to pump enough blood to meet the body’s needs. Heart failure involving the left ventricle of the heart can be systolic or diastolic. The left ventricle is ...

Left sided heart failure occurs when there is weakness or damage in the left side of the heart. Right sided heart failure develops when there is weakness of the muscles in the right side of the heart.